Search
-
Audience Measurement in the Data Age
In this paper, we outline ten predictions for the future of audience measurement. It is an important area of expertise for Ipsos. We measure the audiences to media content in more than 70 countries. This includes those accessing this content via both traditional and digital means.
-
Side-by-side Social Intelligence
Using the analysis and synthesis of social data to enhance and complement our primary research. We live in a digital world where mobile technology allows us to spend more and more time on social media.
-
Mobile
Over the past few years, we have seen an increased proliferation of mobile across the world. Not only have we seen the number of mobile users grow worldwide, but we’ve witnessed increased engagement of consumers with their mobile devices for a variety of everyday activities, whether it’s watching videos, shopping and making purchases, or simply accessing the internet. We are now past the mobile tipping point, with mobile overtaking fixed internet access in many markets, across developed and developing economies. Consumer interactions with brands are, more than ever before, fragmented and multi-layered. Consumers are leading busy lives, and multi-task routinely in their day. Consequently, many of the planned brand exposures are missed and recall relevancy is eroding faster than expected.
-
Communities
Communities enable collaborative environments for brands to interact with people in real-time. They help you build insights, drive innovation and gain influence by accessing on-tap audiences eager to provide input that will have an impact.
-
Ipsos Most Awarded Research Agency at MRIA Event
Ipsos in Canada wins 4 in 8 awards at Marketing Research and Intelligence Association (MRIA) conference. Ipsos and its clients were recently honoured at the MRIA Awards during the 2016 National Conference in Montreal.
-
Who Will Win the Race to Treat NASH?
Non-alcoholic Steatohepatitis, or NASH, is a liver disease characterized by rising prevalence, low diagnosis and a lack of therapies approved for treatment. All of these factors combine to make NASH a priority for the healthcare industry – and, potentially, a multi-billion-dollar market. Accordingly, the race is now on among several pharma companies to develop the first effective pharmacotherapy to treat NASH.
-
Who Is Buying Luxury Goods In Asia?
What is the difference between luxury and mass market today? As premium brands grow and deliver constantly new experiences and personalised services, they are redefining the frontier between the two worlds, which is now more blurred than ever.
-
Branded Content - Optimising For Brand Impact From Development To Measurement
Content is king, or is it context? One thing for sure is the framework for successful branded content is resonance for people with the Content, Platform and Brand.
-
[EVENT] Research Renovation at ESOMAR 2016
The 2016 ESOMAR Latin America Congress which recently took place in Bogota was themed "Research Renovation." Ipsos had a strong visibility at the conference.
-
Clearing the Fog on Neuroscience
This study addresses some of the misunderstandings around what neuroscience is and what it can and can’t do.